Real‐world effectiveness and drug survival of guselkumab over a period of 3 years in moderate‐to‐severe plaque psoriasis, including difficult‐to‐treat areas - Rompoti, Natalia; Vergou, Theognosia; Stefanaki, Irene; Vavouli, Charitomeni; Koumprentziotis, Ioannis‐Alexios; Panagakis, Pantelis; Papoutsaki, Marina; Politou, Maria; Befon, Angeliki; Kousta, Fiori; Lazou, Eleni; Zaimi, Maria; et al. (International journal of dermatology, 2024)